Tenet Healthcare (THC)
(Delayed Data from NYSE)
$115.95 USD
+3.66 (3.26%)
Updated May 1, 2024 04:00 PM ET
After-Market: $115.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$115.95 USD
+3.66 (3.26%)
Updated May 1, 2024 04:00 PM ET
After-Market: $115.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Zacks News
Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $89.22, signifying a -1.12% move from its prior day's close.
Brookdale Senior's (BKD) Q4 Loss Widens, Shares Drop 13%
by Zacks Equity Research
Brookdale Senior's (BKD) Q4 results were hit by inflationary challenges, an increase in facility operating lease expense and higher income tax provision. It expects adjusted EBITDA within $90-$95 million in first-quarter 2024.
Teladoc Health (TDOC) Q4 Loss Narrows on Lower Expenses
by Zacks Equity Research
Teladoc Health's (TDOC) Q4 results were aided by strong contributions from the Integrated Care unit and a decline in restructuring costs. Management targets adjusted EBITDA at a minimum of $425 million in 2025.
Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations
by Zacks Equity Research
Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Can Tenet's (THC) Q4 Earnings Beat on Rising Patient Admissions?
by Zacks Equity Research
Tenet's (THC) fourth-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.
Gear Up for Tenet (THC) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Strength Seen in Tenet (THC): Can Its 7.7% Jump Turn into More Strength?
by Zacks Equity Research
Tenet (THC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
HCA Healthcare (HCA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 16.83% and 4.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $83.57, moving +0.82% from the previous trading session.
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Tenet Healthcare (THC) closed at $81.40, indicating a -0.94% shift from the previous trading day.
Tenet Healthcare (THC) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the latest trading session, Tenet Healthcare (THC) closed at $79.36, marking a +0.04% move from the previous day.
Tenet Healthcare (THC) Gains 60% in a Year: More Room to Run?
by Zacks Equity Research
Diversified treatment network, solid patient volumes in the Hospital segment and robust cash flows continue to drive Tenet Healthcare (THC).
Tenet Healthcare (THC) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $75.56 in the latest trading session, marking a +0.77% move from the prior day.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks to Watch Amid Promising Industry Trends
by Kaibalya Pravo Dey
Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.
Why Is Tenet (THC) Up 23.8% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet (THC) to Divest 3 Hospitals to Novant to Reduce Debt
by Zacks Equity Research
Tenet (THC) expects the divestment of the three South Carolina hospitals to fetch around $2.4 billion in cash.
Tenet Healthcare (THC) Q3 Earnings Beat on Solid Ambulatory Care
by Zacks Equity Research
Tenet Healthcare's (THC) Q3 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.43-$6.05 for 2023.
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 20% and 1%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.